Enhanced brain-derived neurotrophic factor signaling in the nucleus accumbens of juvenile rats

Developmental Neuroscience

Volumn 35, Issue 5, 2013, Pages 384-395

  Perreault, Melissa L ^a   Fan, Theresa ^a   O'Dowd, Brian F ^a   George, Susan R ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brain derived neurotrophic factor; Juveniles; Nucleus accumbens; Prefrontal cortex; SKF 83959; Tropomyosin receptor kinase B

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 5 RECEPTOR; NEUROTROPHIN RECEPTOR P75;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; IMMUNOBLOTTING; MALE; MENTAL HEALTH; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; RAT; SCANNING ELECTRON MICROSCOPY; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; AGE FACTORS; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CAUDATE NUCLEUS; DOPAMINE AGONISTS; MALE; NEURONS; NUCLEUS ACCUMBENS; PHOSPHORYLATION; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKB; SIGNAL TRANSDUCTION;

EID: 84887482166     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000351026     Document Type: Article

References (76)

1. Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A: Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 2003; 60: 837-844.
2. Patton GC, Viner R: Pubertal transitions in health. Lancet 2007; 369: 1130-1139.
3. Zakharova E, Leoni G, Kichko I, Izenwasser S: Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats. Behav Brain Res 2009; 198: 45-50.
4. Zakharova E, Wade D, Izenwasser S: Sensitivity to cocaine conditioned reward depends on sex and age. Pharmacol Biochem Behav 2009; 92: 131-134.
5. Shahbazi M, Moffett AM, Williams BF, Frantz KJ: Age-and sex-dependent amphetamine self-administration in rats. Psychopharmacology (Berl) 2008; 196: 71-81.
6. Anker JJ, Carroll ME: Reinstatement of cocaine seeking induced by drugs, cues, and stress in adolescent and adult rats. Psychopharmacology (Berl) 2010; 208: 211-222.
7. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM: BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991; 350: 230-232.
8. Hyman C, Juhasz M, Jackson C, Wright P, Ip NY, Lindsay RM: Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J Neurosci 1994; 14: 335-347.
9. Kohara K, Yasuda H, Huang Y, Adachi N, Sohya K, Tsumoto T: A local reduction in cortical GABAergic synapses after a loss of endogenous brain-derived neurotrophic factor, as revealed by single-cell gene knock-out method. J Neurosci 2007; 27: 7234-7244.
10. Ventimiglia R, Mather PE, Jones BE, Lindsay RM: The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci 1995; 7: 213-222.
11. Hasbi A, Fan T, Alijaniaram M, Nguyen T, Perreault ML, O'Dowd BF, George SR: Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc Natl Acad Sci USA 2009; 106: 21377-21382.
12. Mizuno K, Carnahan J, Nawa H: Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev Biol 1994; 165: 243-256.
13. Autry AE, Monteggia LM: Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 2012; 64: 238-258.
14. Berry A, Bellisario V, Capoccia S, Tirassa P, Calza A, Alleva E, Cirulli F: Social deprivation stress is a triggering factor for the emergence of anxiety-and depression-like behaviours and leads to reduced brain BDNF levels in C57BL/6J mice. Psychoneuroendocrinology 2012; 37: 762-772.
15. Reus GZ, Abelaira HM, Stringari RB, Fries GR, Kapczinski F, Quevedo J: Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats. Metab Brain Dis 2012; 27: 175-182.
16. Snigdha S, Neill JC, McLean SL, Shemar GK, Cruise L, Shahid M, Henry B: Phencyclidine (PCP)-induced disruption in cognitive performance is gender-specific and associated with a reduction in brain-derived neurotrophic factor (BDNF) in specific regions of the female rat brain. J Mol Neurosci 2011; 43: 337-345.
17. Graham DL, Edwards S, Bachtell RK, DiLeone RJ, Rios M, Self DW: Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci 2007; 10: 1029-1037.
18. Graham DL, Krishnan V, Larson EB, Graham A, Edwards S, Bachtell RK, Simmons D, Gent LM, Berton O, Bolanos CA, DiLeone RJ, Parada LF, Nestler EJ, Self DW: Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine reward. Biol Psychiatry 2009; 65: 696-701.
19. McGinty JF, Whitfield TW Jr, Berglind WJ: Brain-derived neurotrophic factor and cocaine addiction. Brain Res 2010; 1314: 183-193.
20. Williams SN, Undieh AS: Dopamine D1-like receptor activation induces brain-derived neurotrophic factor protein expression. Neuroreport 2009; 20: 606-610.
21. Perreault ML, Jones-Tabah J, O'Dowd BF, George SR: A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex. Int J Neuropsychopharmacol 2012; 25: 1-7.
22. Perreault ML, Fan T, Alijaniaram M, O'Dowd BF, George SR: Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2. PLoS One 2012; 7:e33348.
23. Brenhouse HC, Andersen SL: Delayed extinction and stronger reinstatement of cocaine conditioned place preference in adolescent rats, compared to adults. Behav Neurosci 2008; 122: 460-465.
24. Andersen SL, Thompson AT, Rutstein M, Hostetter JC, Teicher MH: Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats. Synapse 2000; 37: 167-169.
25. Teicher MH, Andersen SL, Hostetter JC Jr: Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Brain Res Dev Brain Res 1995; 89: 167-172.
26. Araki KY, Sims JR, Bhide PG: Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre-and postnatal development. Brain Res 2007; 1156: 31-45.
27. Lee SP, So CH, Rashid AJ, Varghese G, Cheng R, Lanca AJ, O'Dowd BF, George SR: Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 2004; 279: 35671-35678.
28. Perreault ML, Hasbi A, Alijaniaram M, Fan T, Varghese G, Fletcher PJ, Seeman P, O'Dowd BF, George SR: The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia. J Biol Chem 2010; 285: 36625-36634.
29. Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R, O'Dowd BF, George SR: D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA 2007; 104: 654-659.
30. Perreault ML, Hasbi A, Alijaniaram M, O'Dowd BF, George SR: Reduced striatal dopamine D1-D2 receptor heteromer expression and behavioural subsensitivity in juvenile rats. Neuroscience 2012; 225: 130-139.
31. Spear LP: The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000; 24: 417-463.
32. Carlino D, De Vanna M, Tongiorgi E: Is Altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions? Neuroscientist 2013; 19: 345-353.
33. Lee R, Kermani P, Teng KK, Hempstead BL: Regulation of cell survival by secreted proneurotrophins. Science 2001; 294: 1945-1948.
34. Jin LQ, Goswami S, Cai G, Zhen X, Friedman E: SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain. J Neurochem 2003; 85: 378-386.
35. Sahu A, Tyeryar KR, Vongtau HO, Sibley DR, Undieh AS: D5 dopamine receptors are required for dopaminergic activation of phospholipase C. Mol Pharmacol 2009; 75: 447-453.
36. So CH, Verma V, Alijaniaram M, Cheng R, Rashid AJ, O'Dowd BF, George SR: Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers. Mol Pharmacol 2009; 75: 843-854.
37. Alderson RF, Curtis R, Alterman AL, Lindsay RM, DiStefano PS: Truncated TrkB mediates the endocytosis and release of BDNF and neurotrophin-4/5 by rat astrocytes and schwann cells in vitro. Brain Res 2000; 871: 210-222.
38. Biffo S, Offenhauser N, Carter BD, Barde YA: Selective binding and internalisation by truncated receptors restrict the availability of BDNF during development. Development 1995; 121: 2461-2470.
39. Eide FF, Vining ER, Eide BL, Zang K, Wang XY, Reichardt LF: Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J Neurosci 1996; 16: 3123-3129.
40. Fenner BM: Truncated TrkB: beyond a dominant negative receptor. Cytokine Growth Factor Rev 2012; 23: 15-24.
41. Yacoubian TA, Lo DC: Truncated and fulllength TrkB receptors regulate distinct modes of dendritic growth. Nat Neurosci 2000; 3: 342-349.
42. Teng HK, Teng KK, Lee R, Wright S, Tevar S, Almeida RD, Kermani P, Torkin R, Chen ZY, Lee FS, Kraemer RT, Nykjaer A, Hempstead BL: ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci 2005; 25: 5455-5463.
43. Fujii T, Kunugi H: p75NTR as a therapeutic target for neuropsychiatric diseases. Curr Mol Pharmacol 2009; 2: 70-76.
44. Migliarini S, Pacini G, Pelosi B, Lunardi G, Pasqualetti M: Lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation. Mol Psychiatry 2012, Sep 25. doi: 10.1038/mp.2012.128. [Epub ahead of print].
45. Patel NJ, Chen MJ, Russo-Neustadt AA: Norepinephrine and nitric oxide promote cell survival signaling in hippocampal neurons. Eur J Pharmacol 2010; 633: 1-9.
46. Liu CY, Jiang XX, Zhu YH, Wei DN: Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine produces antidepressant effects in rats: role of brainderived neurotrophic factor. Neuroscience 2012; 223: 219-224.
47. Khundakar AA, Zetterstrom TS: Effects of GABAB ligands alone and in combination with paroxetine on hippocampal BDNF gene expression. Eur J Pharmacol 2011; 671: 33-38.
48. Andersen SL: Changes in the second messenger cyclic AMP during development may underlie motoric symptoms in attention deficit/hyperactivity disorder (ADHD). Behav Brain Res 2002; 130: 197-201.
49. Undie AS, Weinstock J, Sarau HM, Friedman E: Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J Neurochem 1994; 62: 2045-2048.
50. Undie AS, Friedman E: Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther 1990; 253: 987-992.
51. Molloy AG, Waddington JL: Assessment of grooming and other behavioural responses to the D-1 dopamine receptor agonist SK&F 38393 and its R-and S-enantiomers in the intact adult rat. Psychopharmacology (Berl) 1987; 92: 164-168.
52. Boyce PJ, Finlay JM: Extracellular dopamine and norepinephrine in the developing rat prefrontal cortex: transient effects of early partial loss of dopamine. Brain Res Bull 2009; 79: 104-110.
53. Staiti AM, Morgane PJ, Galler JR, Grivetti JY, Bass DC, Mokler DJ: A microdialysis study of the medial prefrontal cortex of adolescent and adult rats. Neuropharmacology 2011; 61: 544-549.
54. Brenhouse HC, Sonntag KC, Andersen SL: Transient D1 dopamine receptor expression on prefrontal cortex projection neurons: relationship to enhanced motivational salience of drug cues in adolescence. J Neurosci 2008; 28: 2375-2382.
55. Counotte DS, Li KW, Wortel J, Gouwenberg Y, Van Der Schors RC, Smit AB, Spijker S: Changes in molecular composition of rat medial prefrontal cortex synapses during adolescent development. Eur J Neurosci 2010; 32: 1452-1460.
56. Baxter GT, Radeke MJ, Kuo RC, Makrides V, Hinkle B, Hoang R, Medina-Selby A, Coit D, Valenzuela P, Feinstein SC: Signal transduction mediated by the truncated trkB receptor isoforms, trkB.T1 and trkB.T2. J Neurosci 1997; 17: 2683-2690.
57. Rose CR, Blum R, Pichler B, Lepier A, Kafitz KW, Konnerth A: Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells. Nature 2003; 426: 74-78.
58. Cheng A, Coksaygan T, Tang H, Khatri R, Balice-Gordon RJ, Rao MS, Mattson MP: Truncated tyrosine kinase B brain-derived neurotrophic factor receptor directs cortical neural stem cells to a glial cell fate by a novel signaling mechanism. J Neurochem 2007; 100: 1515-1530.
59. Gomes JR, Costa JT, Melo CV, Felizzi F, Monteiro P, Pinto MJ, Inacio AR, Wieloch T, Almeida RD, Graos M, Duarte CB: Excitotoxicity downregulates TrkB.FL signaling and upregulates the neuroprotective truncated TrkB receptors in cultured hippocampal and striatal neurons. J Neurosci 2012; 32: 4610-4622.
60. Ji Y, Pang PT, Feng L, Lu B: Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neurons. Nat Neurosci 2005; 8: 164-172.
61. Hartmann M, Brigadski T, Erdmann KS, Holtmann B, Sendtner M, Narz F, Lessmann V: Truncated TrkB receptor-induced outgrowth of dendritic filopodia involves the p75 neurotrophin receptor. J Cell Sci 2004; 117: 5803-5814.
62. Woo NH, Teng HK, Siao CJ, Chiaruttini C, Pang PT, Milner TA, Hempstead BL, Lu B: Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci 2005; 8: 1069-1077.
63. Marsden WN: Stressor-induced NMDAR dysfunction as a unifying hypothesis for the aetiology, pathogenesis and comorbidity of clinical depression. Med Hypotheses 2011; 77: 508-528.
64. Pei L, Li S, Wang M, Diwan M, Anisman H, Fletcher PJ, Nobrega JN, Liu F: Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects. Nat Med 2010; 16: 1393-1395.
65. Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J: Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treatment 2012; 2012: 916198.
66. Chambers RA, Taylor JR, Potenza MN: Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 2003; 160: 1041-1052.
67. Hashimoto T, Bergen SE, Nguyen QL, Xu B, Monteggia LM, Pierri JN, Sun Z, Sampson AR, Lewis DA: Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci 2005; 25: 372-383.
68. Favalli G, Li J, Belmonte-de-Abreu P, Wong AH, Daskalakis ZJ: The role of BDNF in the pathophysiology and treatment of schizophrenia. J Psychiatr Res 2012; 46: 1-11.
69. Chao HM, Kao HT, Porton B: BDNF Val66Met variant and age of onset in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:505-506.
70. Narita M, Aoki K, Takagi M, Yajima Y, Suzuki T: Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience 2003; 119: 767-775.
71. Corominas M, Roncero C, Ribases M, Castells X, Casas M: Brain-derived neurotrophic factor and its intracellular signaling pathways in cocaine addiction. Neuropsychobiology 2007; 55: 2-13.
72. Bahi A, Boyer F, Chandrasekar V, Dreyer JL: Role of accumbens BDNF and TrkB in cocaine-induced psychomotor sensitization, conditioned-place preference, and reinstatement in rats. Psychopharmacology (Berl) 2008; 199: 169-182.
73. Sadri-Vakili G, Kumaresan V, Schmidt HD, Famous KR, Chawla P, Vassoler FM, Overland RP, Xia E, Bass CE, Terwilliger EF, Pierce RC, Cha JH: Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. J Neurosci 2010; 30: 11735-11744.
74. Berglind WJ, See RE, Fuchs RA, Ghee SM, Whitfield TW Jr, Miller SW, McGinty JF: A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats. Eur J Neurosci 2007; 26: 757-766.
75. Whitfield TW Jr, Shi X, Sun WL, McGinty JF: The suppressive effect of an intra-prefrontal cortical infusion of BDNF on cocaine-seeking is Trk receptor and extracellular signal-regulated protein kinase mitogen-activated protein kinase dependent. J Neurosci 2011; 31: 834-842.
76. Berglind WJ, Whitfield TW Jr, LaLumiere RT, Kalivas PW, McGinty JF: A single intra-PFC infusion of BDNF prevents cocaine-induced alterations in extracellular glutamate within the nucleus accumbens. J Neurosci 2009; 29: 3715-3719.